InRule Technology®, creator of InRule® the premier .NET Business Rule Management System for the Microsoft platform, announced today that it is increasing its investment in Public and Private Sector Healthcare by expanding its partner network and developing additional technology that will enable healthcare solutions for .NET applications and Microsoft Dynamics® CRM.
A member of the Microsoft Health and Human Services Alliance, InRule Technology is seeing growing customer success in both the private sector with clients such as Access Mediquip, and in the public sector where InRule has been deployed in Medicaid Management Information Systems in Ohio, Oklahoma, Georgia, and Florida. This momentum is accelerating with increased demand, particularly in the areas of Integrated Eligibility; Health Insurance Exchange (HIX); Health Plan Sales and Service; Chronic Disease Population Management; and case management based on Microsoft Dynamics CRM.
By making complex decision logic transparent and easy to manage, InRule helps healthcare organizations implement complex logic more quickly and manage it more effectively over time.
“While InRule continues to be the leading .NET business rule solution for organizations in any industry, we are increasing our investment in the healthcare market,” said Paul Hessinger, CEO. “To improve our ability to deliver solutions we are expanding our partner ecosystem to focus on healthcare and Microsoft Dynamics CRM. Our vision is to improve the effectiveness of how our customers put policy into practice, including federal, state, and local polices as well as corporate policies and governance.”
InRule Technology’s partner ecosystem is expanding to add key partners with proven success with private and public sector healthcare clients on the Microsoft platform. The Company is also investing in technical innovations such as InRule for Microsoft Dynamics CRM, which will improve the out-of-the-box experience for clients wanting to streamline the management of complex logic within Microsoft Dynamics CRM.
All trademarks referenced herein belong to their respective companies.